By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Everon Biosciences 

640 Ellicott Street
Suite 444
Buffalo  New York  14203  U.S.A.
Phone: 716-858-3055 Fax: 716-858-3044


Everon Biosciences, Inc. was founded in 2010 with the goal of developing anti-aging medicines. Company’s scientific program and vision are based on principles of eradicating the cellular foundations of aging formulated by Prof. Andrei Gudkov, Senior Vice President of Research Programming and Development of Roswell Park Cancer Institute, the world’s oldest cancer research center. From the very beginning, the institute has been Everon’s supportive shareholder and a reliable partner, providing access to its rich technical infrastructure and its scientists and physicians. This strategic collaboration resulted in the development of pharmacological and immunological approaches to treatment of age-related frailty. Everon holds a unique position among recently launched anti-aging companies in its approach to the treatment of aging from all major R&D aspects: mechanistic understanding of aging process, access to targets, availability of proprietary drug candidates, strong preclinical efficacy indications, the development of diagnostic tools and clinical strategy.




Founder and CEO: Alexander Polinsky Ph.D.

Founder and CSO: Andrei Gudkov Ph.D., DSci

Founder and VP, Research: Olga Chernova Ph.D.

Director of Operations: Aleksandra Kotlyarova

Key Statistics

Ownership: Private

Web Site: Everon Biosciences


Company News